Projects

This project will develop bioengineered extracellular vesicles as a proof of concept novel modality to deliver therapeutic anticancer nucleic acids. We will optimize scalable bioreactor production and establish their bioactivity in vitro. Efficacy and biodistribution will be evaluated in preclinical animal models of prostate cancer.

Four-dimensional functional ultrasound of the brain will help neurosurgeon to operate precise and safe.

TRIUMPH develops a comprehensive, clinically and pathophysiologically meaningful AF measure to guide personalized AF management.

An app to detect mild language disorders in neurological patients will be designed and standardized.

Targeting the glyco-immune checkpoint receptor Siglec-10 for immune modulation in cancer and autoimmune diseases

PRIME-TIME develops personalized minimal invasive diagnostics to predict, prevent and monitor disease-activity of hematological cancers.

Radboudumc and TropIQ Health Sciences collaborate to find new ways to stop the spread of mosquito-borne viruses

APOLLO-2 will deliver an innovative therapy to fight fibroblast-driven diseases like scleroderma.

The integration of pan-genomics, population dynamics and clinical outcomes to elucidate emerging pathogen threats using machine learning.

OSCAR will faithfully mimic the anatomy and physiology of human bone to study bone metastasis